CION Investment Corp. 10-Q Summary
Business Context and Reporting Period
Company: CION Investment Corporation (CION)
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: September 30, 2013
Business Model: CION is a non-diversified, closed-end management investment company regulated as a Business Development Company (BDC). It invests primarily in senior secured loans and second lien loans of private U.S. middle-market companies. The company utilizes a Total Return Swap (TRS) to gain economic exposure to a leveraged portfolio of loans without direct ownership.
Key Financial Metrics
| Metric | Three Months Ended Sep 30, 2013 | Nine Months Ended Sep 30, 2013 |
|---|---|---|
| Investment Income | $494,701 | $808,321 |
| Net Investment Income | $602,378 | $710,587 |
| Net Increase in Net Assets from Operations | $1,907,606 | $3,225,380 |
| Net Asset Value (NAV) per Share | $9.29 | $9.29 |
| Total Assets | $77,073,568 | $77,073,568 |
| Total Liabilities | $5,426,130 | $5,426,130 |
| Shareholders' Equity | $71,647,438 | $71,647,438 |
| Cash and Short-Term Investments | $11,824,039 | $11,824,039 |
Note: Net Investment Income includes significant expense reimbursements from affiliates (see Material Changes).
Material Changes vs. Prior Period
- Portfolio Growth: Total investments at fair value increased from $3.8 million at December 31, 2012, to $52.2 million at September 30, 2013. This growth is driven by the deployment of capital raised through a continuous public offering.
- TRS Expansion: The notional amount of the Total Return Swap (TRS) with Citibank grew from $2.9 million to $71.9 million, significantly increasing the company's exposure to leveraged loans.
- Expense Reimbursements: The company recorded $1.3 million in expense reimbursements from its affiliate, ICON Investment Group (IIG), for the quarter, and $3.3 million for the nine-month period. Without these reimbursements, the company would have reported a net operating loss.
- Distributions: The company declared distributions totaling $1.8 million for the nine months ended September 30, 2013. Approximately 38.8% of these distributions were funded by expense reimbursements from IIG, while 61.2% were funded by realized gains.
Guidance, Outlook, and Risks
- Outlook: Management expects the investment portfolio to continue growing as the company deploys proceeds from its continuous public offering. The company targets a gross annual yield of approximately 7.33% on its direct investments.
- Expense Support: IIG has agreed to reimburse expenses to ensure distributions are not paid from offering proceeds until the company achieves economies of scale. These reimbursements are conditional and subject to recoupment if future income exceeds distributions.
- Market Risk: The portfolio is 100% exposed to variable interest rates (floating rate loans). While rising rates generally increase income, they also increase the cost of the TRS financing. A 100 basis point increase in LIBOR is estimated to decrease net interest income by approximately $610,000 over a twelve-month period due to the specific structure of the TRS.
- Valuation Risk: A significant portion of the portfolio (Level 3 assets) is valued using unobservable inputs, including discounted cash flow models and broker quotes, which involves significant management judgment.
Investor Verification Checklist
- Sustainability of Distributions: Verify the proportion of distributions funded by affiliate expense reimbursements versus actual investment income, as reimbursements are subject to recoupment.
- TRS Counterparty Risk: Review the terms of the Total Return Swap with Citibank, including collateral requirements and early termination fees (estimated at $204,000 as of period end).
- Asset Coverage Ratio: Confirm the company maintains the required asset coverage ratio (2.38x as of Sep 30, 2013) to comply with BDC regulations under the 1940 Act.
- Expense Cap: Monitor the 1.5% cap on organization and offering expenses relative to gross proceeds raised to assess future reimbursement obligations.
- Portfolio Concentration: Review the concentration of investments in specific industries (e.g., Healthcare at 17.1%) and the credit quality ratings (100% of the portfolio was rated "2" as of period end).